AZTR
Price
$0.41
Change
-$0.02 (-4.65%)
Updated
Dec 18, 04:03 PM (EDT)
86 days until earnings call
MMIRF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Dec 16 closing price
Ad is loading...

AZTR vs MMIRF

Header iconAZTR vs MMIRF Comparison
Open Charts AZTR vs MMIRFBanner chart's image
Azitra
Price$0.41
Change-$0.02 (-4.65%)
Volume$2.01K
CapitalizationN/A
Medmira
Price$0.05
Change-$0.00 (-0.00%)
Volume$73.75K
CapitalizationN/A
AZTR vs MMIRF Comparison Chart
Loading...
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTR vs. MMIRF commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTR is a Hold and MMIRF is a Sell.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (AZTR: $0.43 vs. MMIRF: $0.05)
Brand notoriety: AZTR and MMIRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AZTR: 229% vs. MMIRF: 283%
Market capitalization -- AZTR: $3.26M vs. MMIRF: $41.9M
AZTR [@Biotechnology] is valued at $3.26M. MMIRF’s [@Biotechnology] market capitalization is $41.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTR’s FA Score shows that 1 FA rating(s) are green whileMMIRF’s FA Score has 1 green FA rating(s).

  • AZTR’s FA Score: 1 green, 4 red.
  • MMIRF’s FA Score: 1 green, 4 red.
According to our system of comparison, MMIRF is a better buy in the long-term than AZTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTR’s TA Score shows that 4 TA indicator(s) are bullish while MMIRF’s TA Score has 3 bullish TA indicator(s).

  • AZTR’s TA Score: 4 bullish, 5 bearish.
  • MMIRF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, MMIRF is a better buy in the short-term than AZTR.

Price Growth

AZTR (@Biotechnology) experienced а -13.05% price change this week, while MMIRF (@Biotechnology) price change was -0.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.42%, and the average quarterly price growth was +4.21%.

Reported Earning Dates

AZTR is expected to report earnings on Mar 14, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MMIRF($41.9M) has a higher market cap than AZTR($3.26M). MMIRF YTD gains are higher at: -18.386 vs. AZTR (-98.453). MMIRF has higher annual earnings (EBITDA): -1.75M vs. AZTR (-12.74M). AZTR has more cash in the bank: 7.26M vs. MMIRF (2.91M). AZTR has less debt than MMIRF: AZTR (643K) vs MMIRF (8.85M). AZTR has higher revenues than MMIRF: AZTR (1.27M) vs MMIRF (383K).
AZTRMMIRFAZTR / MMIRF
Capitalization3.26M41.9M8%
EBITDA-12.74M-1.75M728%
Gain YTD-98.453-18.386535%
P/E Ratio0.00N/A-
Revenue1.27M383K333%
Total Cash7.26M2.91M250%
Total Debt643K8.85M7%
FUNDAMENTALS RATINGS
MMIRF: Fundamental Ratings
MMIRF
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AZTRMMIRF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 20 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VRIG25.190.01
+0.04%
Invesco Variable Rate Investment Grd ETF
LQD108.870.01
+0.01%
iShares iBoxx $ Invmt Grade Corp Bd ETF
HYTR21.88-0.01
-0.05%
Counterpoint High Yield Trend ETF
XBAP34.19-0.03
-0.09%
Innovator US Eq Acltd 9 Bfr ETFTM April
SVXY52.21-0.62
-1.17%
ProShares Short VIX Short-Term Futures

AZTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTR has been closely correlated with DARE. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if AZTR jumps, then DARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTR
1D Price
Change %
AZTR100%
-2.71%
DARE - AZTR
73%
Closely correlated
+0.31%
SNTI - AZTR
31%
Poorly correlated
+0.78%
KNSA - AZTR
29%
Poorly correlated
+0.84%
SLRX - AZTR
25%
Poorly correlated
-4.06%
MMIRF - AZTR
24%
Poorly correlated
N/A
More

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and NWPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and NWPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
NWPHF - MMIRF
30%
Poorly correlated
N/A
TECX - MMIRF
29%
Poorly correlated
+6.76%
AZTR - MMIRF
24%
Poorly correlated
-2.71%
SRPT - MMIRF
22%
Poorly correlated
-0.81%
SAGE - MMIRF
22%
Poorly correlated
-1.40%
More